Vaxxinity, Inc. (VAXX)
USD 0.05
(200.0%)
USD 0.05
(200.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 56.05 Million USD | -99.92% |
| 2022 | 75.97 Million USD | -38.33% |
| 2021 | 123.2 Million USD | 275.77% |
| 2020 | 32.78 Million USD | 140.0% |
| 2019 | 13.66 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q3 | 13.44 Million USD | -6.81% |
| 2023 Q2 | 14.42 Million USD | -23.29% |
| 2023 Q1 | 18.8 Million USD | -9.68% |
| 2023 FY | 56.05 Million USD | -26.23% |
| 2023 Q4 | 11.19 Million USD | -16.74% |
| 2022 Q4 | 20.82 Million USD | 5.34% |
| 2022 Q3 | 19.76 Million USD | 14.77% |
| 2022 Q2 | 17.22 Million USD | -5.18% |
| 2022 Q1 | 18.16 Million USD | -62.04% |
| 2022 FY | 75.97 Million USD | -38.33% |
| 2021 Q4 | 47.85 Million USD | 57.85% |
| 2021 Q3 | 30.31 Million USD | 21.91% |
| 2021 Q2 | 24.86 Million USD | 22.67% |
| 2021 FY | 123.2 Million USD | 275.77% |
| 2021 Q1 | 20.27 Million USD | 80.6% |
| 2020 Q2 | 6.02 Million USD | 171052.75% |
| 2020 FY | 32.78 Million USD | 140.0% |
| 2020 Q1 | 3522.00 USD | 0.0% |
| 2020 Q4 | 11.22 Million USD | -13.58% |
| 2020 Q3 | 12.98 Million USD | 115.48% |
| 2019 FY | 13.66 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| America Great Health | 661.23 Thousand USD | -8376.752% |
| Ampio Pharmaceuticals, Inc. | 9.26 Million USD | -504.78% |
| Aridis Pharmaceuticals, Inc. | 29.99 Million USD | -86.88% |
| Biora Therapeutics, Inc. | 67.14 Million USD | 16.525% |
| Bio-Path Holdings, Inc. | 15.84 Million USD | -253.79% |
| Better Therapeutics, Inc. | 38.26 Million USD | -46.493% |
| Calithera Biosciences, Inc. | 40.68 Million USD | -37.755% |
| Comera Life Sciences Holdings, Inc. | 12.39 Million USD | -352.289% |
| Gene Biotherapeutics, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | 33.84 Million USD | -65.616% |
| Eloxx Pharmaceuticals, Inc. | 34.41 Million USD | -62.849% |
| Evelo Biosciences, Inc. | 108.46 Million USD | 48.324% |
| Evolutionary Genomics, Inc. | 992.8 Thousand USD | -5545.698% |
| Finch Therapeutics Group, Inc. | 32.58 Million USD | -71.994% |
| Galera Therapeutics, Inc. | 46.95 Million USD | -19.382% |
| Innovation1 Biotech Inc. | 1.21 Million USD | -4514.436% |
| Kiromic BioPharma, Inc. | 19.93 Million USD | -181.108% |
| Molecular Templates, Inc. | 63.09 Million USD | 11.158% |
| Navidea Biopharmaceuticals, Inc. | 13.93 Million USD | -302.33% |
| NexImmune, Inc. | 28.16 Million USD | -98.992% |
| Orgenesis Inc. | 45.75 Million USD | -22.497% |
| Panbela Therapeutics, Inc. | 25.64 Million USD | -118.548% |
| Point of Care Nano-Technology, Inc. | 73.41 Thousand USD | -76247.118% |
| PaxMedica, Inc. Common Stock | 16.14 Million USD | -247.167% |
| Scopus BioPharma Inc. | 11.71 Million USD | -378.46% |
| Sorrento Therapeutics, Inc. | 403.56 Million USD | 86.111% |
| Statera Biopharma, Inc. | 28.82 Million USD | -94.422% |
| TRACON Pharmaceuticals, Inc. | 18.92 Million USD | -196.112% |
| Trevena, Inc. | 38.41 Million USD | -45.917% |
| Vaccinex, Inc. | 23.45 Million USD | -138.973% |
| Vicapsys Life Sciences, Inc. | 1.04 Million USD | -5253.599% |
| Viracta Therapeutics, Inc. | 50.69 Million USD | -10.57% |
| ZIVO Bioscience, Inc. | 7.27 Million USD | -670.501% |